Credo Technology Group vs. Marvell Technology: Which Technology Stock Is a Better Buy in 2026?

Credo Technology’s FY 2026 revenue is reported at ~$1.3B, up ~205.7% YoY, alongside net income of ~$472.3M and FCF of ~$407M (noting stock-based comp ~$39.3% of OCF). Marvell’s FY 2026 revenue is reported at ~$8.2B, up ~42.1% YoY, with net income of ~$2.7B and FCF of ~$1.4B (stock-based comp ~$33.8% of OCF), plus an expanded Amazon Trainium AI partnership and a cited $2B strategic investment from Nvidia. The article favors Marvell over Credo, highlighting customer-concentration risk at both firms (Credo: top 10 ~90% of revenue; Marvell: one distributor ~37%, one customer ~14%) and valuation differences (Forward P/E: 39.6x vs 60.5x).

Analysis

The market is treating this as a simple growth-versus-scale comparison, but the real variable is durability of socket ownership. In AI interconnect, once a supplier is embedded in a hyperscaler design cycle, revenue can compound for several quarters — or reverse just as fast if a platform standard shifts. That makes CRDO the cleaner torque trade on near-term AI capex, while MRVL is the more diversified but also more execution-sensitive way to express the same spend wave.

Second-order effects matter more than the headline growth rates. If hyperscalers keep expanding port counts, adjacent names like ALAB can benefit as procurement teams seek redundancy across retimers, cables, and connectivity layers; concentration risk at CRDO can actually force buyers to dual-source sooner, capping margin power. For MRVL, broader product breadth helps win wallet share, but channel concentration and integration risk mean the stock can lag fundamentals if inventory or M&A synergy capture disappoints.

Contrarian read: the consensus may be too quick to label MRVL the “safer” AI winner and CRDO the fragile one. In the current phase of the AI buildout, the market often rewards the pure-play that owns a critical bottleneck more than the diversified incumbent that only participates across several segments. The thesis is wrong if CRDO’s next few updates show customer breadth not improving or if MRVL’s AI pipeline converts into clear multi-quarter guide raises; otherwise the relative-performance setup still favors the higher-growth interconnect stack.

Key Decisions for Investors

• Long CRDO / short MRVL as a 1-3 month relative-value trade on AI interconnect breadth: enter on post-rally weakness, target ~10-15% spread compression; exit if CRDO guidance slows materially or MRVL prints a clear upside re-acceleration.
• Use ALAB as a secondary long in any pullback if hyperscaler redundancy demand rises; the trade works best if procurement diversification becomes visible in channel checks over the next 1-2 earnings cycles.
• If you want lower beta exposure to the same capex cycle, own NVDA or AMZN instead of chasing the semis directly; these are cleaner beneficiaries of AI spend cadence, not single-supplier execution.
• Watch MRVL for a short-on-strength setup if integration commentary or distributor inventory looks soft; the stock is vulnerable to multiple compression if AI revenue growth decelerates before synergy capture becomes visible.
• Set a thesis-failure alert on CRDO if customer concentration remains effectively unchanged after the next report; without diversification, the market will eventually discount the growth rate more aggressively.